scispace - formally typeset
P

Peiwei Chai

Researcher at Shanghai Jiao Tong University

Publications -  50
Citations -  1208

Peiwei Chai is an academic researcher from Shanghai Jiao Tong University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 12, co-authored 35 publications receiving 535 citations.

Papers
More filters
Journal ArticleDOI

Novel insights on m 6 A RNA methylation in tumorigenesis: a double-edged sword.

TL;DR: It is clarified that the abnormal changes in the m6A enrichment of specific loci contribute to tumour occurrence and development, thereby representing a novel anti-cancer strategy by restoration to balanced RNA methylation in tumour cells.
Journal ArticleDOI

Histone lactylation drives oncogenesis by facilitating m 6 A reader protein YTHDF2 expression in ocular melanoma

TL;DR: In this paper, the role of histone lactylation in tumorigenesis remains unclear, but it is shown that histone Lactylation is elevated in tumors and is associated with poor prognosis of ocular melanoma.
Journal ArticleDOI

Emancipating Target-Functionalized Carbon Dots from Autophagy Vesicles for a Novel Visualized Tumor Therapy

TL;DR: An autophagy regulation strategy is reported by emancipating target‐functionalized carbon dots from autophagic vesicles for the efficient visualized tumor therapy by achieving therapeutic effects with high performance in 26 types of tumor cell lines.
Journal ArticleDOI

m6A modification suppresses ocular melanoma through modulating HINT2 mRNA translation.

TL;DR: It is shown that RNA methylation significantly inhibits the progression of UM and CM, and uncovers a critical function for m6A methylation in ocular melanoma and provides additional insight into the understanding of m 6A modification.
Journal ArticleDOI

Genetic alteration, RNA expression, and DNA methylation profiling of coronavirus disease 2019 (COVID-19) receptor ACE2 in malignancies: a pan-cancer analysis.

TL;DR: This study for the first time curated both genetic and epigenetic variations of ACE2 in human malignancies in human cancers, and because this study is a bioinformatics assay, further functional and clinical validation is warranted.